Volatile Organic Compound Analysis in Biomedical Diagnosis Applications
168,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
84 °P sammeln
  • Gebundenes Buch

Presents a thought-provoking state-of-the-art picture of how volatile compounds are used in metabolomics. It provides a thorough description of what are volatile organic compounds, why are they important in biomedicine, and what are the analytical platforms used. It also looks at multivariate analysis and databases needs.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Presents a thought-provoking state-of-the-art picture of how volatile compounds are used in metabolomics. It provides a thorough description of what are volatile organic compounds, why are they important in biomedicine, and what are the analytical platforms used. It also looks at multivariate analysis and databases needs.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Raquel Cumeras, PhD, received a Starting Grant from the Programa Martí Franquès at the University Rovira i Virgili (URV, Tarragona, Catalonia) in 2017 to identify reliable and specific urinary bladder cancer biomarkers using metabolomics and crosslinking them with other urinary cancers (prostate and kidney). After completing her PhD, Dr. Cumeras spent two years as a postdoctoral researcher at the University of California Davis, and after a sabbatical year for maternity, she was a postdoc at the Institute of Bioengineering of Catalonia (IBEC, Barcelona, Catalonia, Spain). Currently, her research is focused not only on the development of metabolomics studies for determining volatile biomarkers but also on cancer metabolomics studies using less invasive samples such as breath, urine, blood, and feces. Xavier Correig, PhD, is a Full Professor at the Universitat Rovira i Virgili (URV, Tarragona, Catalonia) and has extensive experience in training and research at the Department of Electronic Engineering. He created and coordinated the Metabolomics Platform (http://metabolomicsplatform.com/), a research infrastructure created by the URV and the CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas). Professor Correig has published more than 200 articles, supervised several PhD students, and created a spin-off company, Biosfer Teslab, which is commercializing the Liposcale Test (a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy).